This study investigates advanced or metastatic solid tumors. It evaluates the use of an investigational medication, known as ART0380, which is being studied alone and in combination with other drugs.
The study focuses on understanding the safety and effectiveness of ART0380. Researchers are looking to learn more about its side effects and how well it works when combined with other treatments.
- Who can participate: Adults with advanced or metastatic solid tumors may participate. Eligibility includes having stopped previous cancer treatments for at least 21 days and having an estimated life expectancy of 12 weeks or more.
- Study details: Participants will take the investigational treatment ART0380, either alone or with additional treatments.
How understandable was the trial content above?
Hard to understand
Easy to understand